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1. Introduction
Rapid technological advances promise a bright fu-
ture for continued progress and innovation in endo-
scopy. Novel optical designs, miniature scanning me-
chanisms, and specific molecular probes are being
developed to acquire greater biological details from
tissue, including metabolic and molecular function.
Instruments are being designed to provide images in
various colors, more depth, and multiple dimensions
that will soon be available for in vivo use. The in-
creased variety of light sources, improved sensitivity
of detectors, and availability of optical fibers are ac-
celerating these engineering breakthroughs.
2. Wide-field endoscopy
Novel methods of wide-field endoscopy are critical
for rapid visualization of large surface areas in hol-
low organs to localize disease and guide tissue biopsy.
Most endoscopes use a small flexible, fiber bundle to
provide illumination and a miniature video charge-
coupled device (CCD) chip located in the distal tip
for image detection [1]. High-resolution and a large
field-of-view (FOV) can also be achieved by provid-
ing illumination with a single scanning optical fiber
in the distal tip [2]. Diffraction-limited images can be
achieved by using the central aperture of the objec-
tive lens. This design can achieve a much smaller in-
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The future of endoscopy will be dictated by rapid tech-
nological advances in the development of light sources,
optical fibers, and miniature scanners that will allow for
images to be collected in multiple spectral regimes, with
greater tissue penetration, and in three dimensions. These
engineering breakthroughs will be integrated with novel
molecular probes that are highly specific for unique pro-
teins to target diseased tissues. Applications include early
cancer detection by imaging molecular changes that oc-
cur before gross morphological abnormalities, persona-
lized medicine by visualizing molecular targets specific
to individual patients, and image guided therapy by loca-
lizing tumor margins and monitoring for recurrence.
Future multi-spectral dual axes confocal endomicroscope
designed with MEMS mirror and piezoelectric actuator
for real-time vertical cross-sectional imaging of specific
molecular probes.
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strument package, and has greater flexibility for per-
forming multi-spectral imaging using red, green, and
blue (RGB) illumination that can eventually be ex-
tended for use in molecular imaging.
2.1 Autofluorescence endoscopy
Early detection by routine white light endoscopy has
led to a decreased incidence and mortality of cancer
of the stomach and colon [3]. However, early detec-
tion remains challenging for flat and depressed le-
sions that have minimal morphological changes to
differentiate pre-malignant from non-malignant mu-
cosa. Over the past decade, there has been consider-
able effort to use differences in intrinsic fluorescence
to detect pre-malignant lesions. Autofluorescence en-
doscopy has been developed to image endogenous
fluorophores in tissue, including collagen, NADH,
flavin, and porphyrins, and chromophores, such as
hemoglobin, which absorbs visible light. Autofluor-
escence images reflect differences in the mucosal
thickness, hemoglobin concentration, fluorophore
distribution and concentration, and tissue microen-
vironment of diseased tissues. This strategy has been
investigated for early detection of cancer in the lung
[4], stomach [5, 6], esophagus [7, 8] and colon [9, 10],
and an example of a flat colonic adenoma is shown
in Figure 1b [11].
The autofluorescence imaging system (AFI, Olym-
pus Medical Systems Corp., Tokyo, Japan), shown in
Figure 1a, combines tissue autofluorescence with re-
flectance [11]. A xenon lamp provides illumination
for autofluorescence excitation (395–475 nm) and
green reflectance (540–560 nm) through a rotation
filter, and two CCD detectors in the distal tip of the
endoscope collect the returning light. The control
unit sends the autofluorescence signal to the green
channel and reflectance to the red and blue. Using
this technique, normal mucosa appears as bright
green autofluorescence background. Regions of in-
creased hemoglobin from ulcerated and inflamed tis-
sue absorb green reflectance, and appear dark green.
Elevated tumors have thickened mucosa and absorb
the autofluorescence signal of the submucosal col-
lagen and appear magenta, a complementary color
of green [11, 12]. However, comparative studies be-
tween AFI and white light endoscopy (WLE) to de-
tect gastric [6] and colonic [11] neoplasias suggest
that although sensitivity is improved by AFI, its spe-
cificity is less than that of WLE, therefore limiting
its clinical usefulness. Using wide-field fluorescence
endoscopes in combination with fluorescent molecu-
lar probes can improve the specificity and clinical
utility of these methodologies.
2.2 Scanning fiber endoscopy
The scanning fiber endoscope (SFE) uses a piezo-
electric tube actuator to rapidly scan a single-mode
optical fiber in a spiral pattern, as shown in Fig-
ure 2a [2]. Light from blue (440 nm), green (523 nm)
and red (635 nm) lasers is delivered simultaneously
through the scanning fiber, and focused by the lens
assembly onto the illumination plane. The returning
light is collected by a ring of multi-mode fibers lo-
cated around the periphery of the housing. The im-
age is then constructed from the full spectrum of the
collected light one pixel at a time. This optical design
allows for a large FOV (>100 deg) to be achieved
by a very small instrument. As a result, this flexible
instrument can be used to provide wide-field images
of biliary and pancreatic ducts [13, 14] with ultrathin
package dimensions (1.2 mm outer diameter) and
with great flexibility (6 mm minimum bend radius).
The SFE was used in a pig to guide the naviga-
tion of a bronchoscope through peripheral airways
for guiding tissue biopsy, as shown in Figure 2b [13].
Also, the bile duct in a pig was imaged by launching
the SFE over a guide wire and through the working
channel of a duodenoscope [14]. Since the RGB illu-
Figure 1 (online color at: www.biophotonics-journal.org) Autofluorescence endoscopy. (a) Illumination in 395–475 and
540–560 nm bands is generated in distal tip of endoscope by xenon lamp using a rotational filter. Autofluorescence (490–
625 nm) and reflectance are collected by two CCD detectors. (b) AFI image of flat colonic adenoma. Used with permission.
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mination sources for the SFE are narrow-band,
wide-field fluorescence imaging is also possible. An
exciting future direction is use of the SFE in combi-
nation with molecular probes to perform targeted
imaging in hollow organs [15]. Moreover, the small
size of the SFE allows for high resolution images to
be collected from the esophagus, stomach, and colon
of mouse models genetically engineered to express
optical reporters to perform longitudinal imaging for
study of molecular mechanisms of disease [16, 17].
This unique combination of spiral scanning and multi-
element optics allows for this flexible fiber instru-
ment to be realized in a miniature package to ap-
proach but not match the high-quality images of
standard medical endoscopes.
3. Confocal and two-photon
endomicroscopy
In confocal endomicroscopy, fluorescence is gener-
ated by single photons in the visible regime that ex-
cite electrons in tissue biomolecules to higher-energy
levels that spontaneously relax to the ground state.
The core of a single mode optical fiber acts as a spa-
tial filter to reject scattered light that originates out
of the focal plane [18]. Two-photon excited fluores-
cence requires two low-energy photons in the near-
infrared (NIR) regime that arrive at the tissue bio-
molecule simultaneously and combine their energies
in order to excite electrons into higher energy levels
[19]. The photon flux required to generate this non-
linear effect is spatially confined to a tiny focal vo-
lume. Both of these techniques perform optical sec-
tioning to produce clear images in turbid tissue that
can be used to generate 3-dimensional volumetric
images.
3.1 Confocal endomicroscopy
Single-photon confocal endomicroscopy systems for
real-time optical biopsies have been extensively de-
veloped since the first demonstration of a fiber-optic
instrument in 1993 [20]. Two endoscope-compatible
confocal systems are now commercially available.
One is based on a miniaturized confocal micro-
scope (Optiscan Pty. Ltd., Victoria, Australia) that is
integrated into the distal tip of a videoendoscope
(EC3870K, Pentax, Tokyo, Japan) [21]. The other
(Mauna Kea Technologies, Paris, France) is based on
a coherent fiber bundle that can be passed down the
instrument channel of most standard medical endo-
scopes [22]. Several groups have demonstrated high
resolution imaging in hollow organs throughout the
body using these instruments [23–30]. These instru-
ments both provide horizontal cross-sectional views,
in a plane parallel to the tissue surface, revealing a
local view of the epithelium along a surface that
tends to have a similar degree of differentiation. This
orientation does not provide information about bio-
logical behavior either above or below this plane, in
the basal-to-luminal direction, where cells can trans-
form to cancer as deep as 500 mm below the tissue
surface [31]. Moreover, horizontal cross sections are
an atypical view of the tissue compared to traditional
H&E-stained biopsy specimens that pathologists are
accustomed to viewing; hence, a trained specialist
must interpret confocal endomicroscopy images.
In contrast, the dual axes architecture is a novel
approach that can achieve a vertical cross-sectional
view, in a plane perpendicular to the tissue surface.
This innovative design employs two low numerical
aperture (NA) objectives for separate illumination
and collection. As a result, high resolution, long
working distance, and deep tissue penetration can be
achieved with an instrument package that can be
Figure 2 (online color at: www.biophotonics-journal.org) Scanning fiber endoscope. (a) Schematic of distal tip of scanning
fiber endoscope, details in text. (b) In vivo image of peripheral airway in a pig. Used with permission.
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scaled down to millimeter dimensions. In addition,
post-objective scanning can provide a much larger
FOV that can produce 3-dimensionsal (3D) volu-
metric images of unprecedented size [32]. The dual-
axes configuration can be scaled down in size to a
5 mm diameter instrument package using a micro-
electro-mechanical systems (MEMS) mirror [33], as
shown in Figure 3a. The micro-mirror maintains the
two beams at an angle q to the optical axis, and can
sweep a diffraction-limited focal volume over an ar-
bitrarily large FOV, limited only by the maximum
deflection angle of the mirror. Because very little of
the light that is scattered by tissue along the illumi-
nation (input) path is collected, a much higher dy-
namic range can be achieved. Consequently, optical
sections can be collected in the vertical cross-section
with NIR light to achieve deep tissue imaging, as
shown in Figure 3b, acquired with a tabletop system
[34]. This image was collected from the squamo-co-
lumnar junction of a patient with Barrett’s esopha-
gus. On the left half, the individual squamous cells
from normal esophageal mucosa can be seen in the
luminal to the basilar direction down to a depth of
500 mm. Over the right half, vertically oriented crypts
with individual mucin-secreting goblet cells asso-
ciated with intestinal metaplasia can be appreciated
as brightly stained vacuoles. This view shows the re-
lationship among tissue micro-structures as they vary
with depth, and provides important diagnostic infor-
mation about variations in the differentiation pattern
of tissue. Although MEMS scanners can be batch
fabricated for mass production, the initial design and
development of functional devices can require a sig-
nificant investment in time and cost.
3.2 Two-photon endomicroscopy
Two-photon endomicroscopy offers a number of ad-
vantages over that of confocal for biological applica-
tions: 1) optical sectioning is inherent to the two-
photon process, greatly reducing tissue scattering
even without need for a confocal pinhole; 2) photo-
bleaching is significantly reduced because the high
intensity excitation is confined to the small focal vo-
lume; and 3) NIR excitation penetrates deeper into
the tissue [35]. The development of two-photon en-
domicroscopy requires the excitation to be delivered
remotely to the tissue by an optical fiber that can
maintain the high intensity of the light by preserving
the short pulse width. Second, the size of the focus-
ing optics must be reduced to millimeter dimensions
while maintaining endoscope flexibility, achromatic
properties over a broad spectral range, and high nu-
merical aperture (>0.4). Third, a compact scanner
must sweep the focal volume over the FOV with suf-
ficient speed to overcome motion artifact.
A two-photon endomicroscope has been devel-
oped based on the spiral piezoelectric scanner [36],
shown in Figure 4a. This system uses a double-clad
fiber to deliver excitation and a GRIN lens for fo-
cusing that is housed within a thin-walled hypoder-
mic tube with outer diameter of 2.4 mm. The in-
strument achieves 1.6 and 11.4 mm resolution in the
lateral and axial, dimensions, respectively. A hori-
zontal cross-sectional image of stratified squamous
epithelium from rat oral mucosa stained with acri-
dine orange at a depth of 50 mm below the tissue sur-
face is shown in Figure 4b. A z-stack of these images
can be generated to produce the 3D volumetric im-
age with a depth of 120 mm, shown in Figure 4c. A
limitation of two-photon endoscopy is the need for
high peak powers and ultra-short pulses, resulting in
expensive laser sources.
4. Miniature scanning and actuation
mechanisms
The proximal location of the scanner has allowed for
the distal end of flexible endoscopes to be ultrathin,
offering the ability to access and image hollow or-
Figure 3 (online color at: www.biophotonics-journal.org) Dual axes confocal endomicroscopy. (a) Scanning of the over-
lapping beams is performed in synchrony with a gimbaled micro-mirror. (b) Vertical cross-sectional image of a neo-
squamous-columnar junction in Barrett’s esophagus collected with tabletop instrument over mucosal depth of 500 mm.
Used with permission.
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gans easily. However, the image quality is limited by
pixilation artifact, and the focus cannot be adjusted
for imaging at different depths. The future of wide-
field and endomicroscopy imaging instruments will
depend on continued progress in the development of
miniature scanning and actuation mechanisms. These
tiny, powerful devices spatially sweep the laser beams
in the horizontal and vertical directions to rapidly
generate 2D and 3D images of tissue. The perfor-
mance of these mechanisms, including speed and
bandwidth, determines the frame rate of the instru-
ment, which should be at least 4 Hz to overcome mo-
tion artifact produced by organ peristalsis, heart beat-
ing, and respiratory breathing.
4.1 Spiral (horizontal) scanning
Spiral scanning is performed using a central optical
fiber that is cantilevered from the tip of a tubular
(bulk) piezoelectric actuator, shown in Figure 5a,
and is used by the SFE [2]. The cantilever length is
the extension of the fiber beyond the distal end of
the tubular piezoelectric actuator, which determines
the resonant frequency. By electrically driving the
tube piezo near the scanning fiber’s fundamental
mode of lateral resonance, the fiber tip motion ex-
periences a mechanical gain of 100 to 200 [37]. Shap-
ing the cross-sectional axial profile along this fiber
optic cantilever from a cylinder to a more complex
shape by acid etching can produce additional gains
of 30% to 100% [38]. Nonetheless, the general coax-
ial design of the SFE is ideal for the compact and
simple design of ultrathin endoscopes.
This approach has been used to scan a double-
clad fiber at a frequency of 1330 Hz [39] for two-
photon endomicroscopy. The probe has a length of
8.2 mm and outer diameter of 2.4 mm, a package
that can be easily integrated into the distal end of a
medical endoscope. The piezoelectric tube is divided
into four quadrants, forming two pairs of drive elec-
trodes. The electrodes are driven with sine and co-
sine waveforms near resonance, 90 out of phase with
Figure 4 (online color at: www.biophotonics-journal.org) Two-photon endomicroscopy. (a) schematic and photo of fiber
scanning instrument with dimensions of 2.4 mm. (b) Fluorescence image at 50 mm depth of rat oral mucosa stained with
acridine orange. (c) 3D volumetric image with 120 mm thickness. Used with permission.
Figure 5 (online color at: www.biophotonics-journal.org) Miniature scanning/actuation mechanisms. (a) Spiral scanner,
(b) MEMS mirror, (c) Piezoelectric z-axis actuator. Used with permission.
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each other, which are then modulated with a sinusoi-
dal waveform to achieve a spiral scan pattern. This
scanner has been the core component for several
two-photon endoscope configurations demonstrated
in recent years [36, 39–43].
4.2 MEMS (horizontal) mirrors
MEMS-based mirrors are promising for endoscopy
because of their small size (0.5–2 mm diameter), high
speed, low power consumption, and relatively high
force output [31]. MEMS-scanners have been used
in several endomicroscopes over the past decade
[32, 33, 44–47]. The mirror used in the dual axes in-
strument is shown in Figure 5b [33]. This device has
a 600  650 mm2 active mirror surface for each beam,
connected together by a strut, and is designed to de-
flect both beams while preserving the overlapping
focal volume without introducing aberrations. This
micro-mirror rotates on a gimbal around an inner
and outer spring in 2 dimensions. Orthogonal rows
of vertical comb drives actuate the micro-mirror
using electrostatic forces. The maximum optical scan
angles are 3.3 on the inner axis and 1.0 on the
outer axis, and the resonance frequencies of the de-
vice are 3.54 kHz and 1.1 kHz, respectively. Images
can be acquired up to 30 frames per second with a
maximum FOV of 800  400 mm2 using post-objec-
tive scanning. Fabrication involves 4 deep-reactive-
ion etching (DRIE) steps that self-align the comb-
drive fingers in the device layers. The mirror sur-
faces are coated with aluminum using a blanket eva-
poration technique to achieve 70% reflectivity at
NIR wavelengths.
Two-photon endoscopes based on MEMS scan-
ners have also been developed. A 1D scanner was
demonstrated based on electrothermal biomorph ac-
tuation, is 1  1 mm2 in size, has a resonance fre-
quency of 165 Hz, and has a maximum rotation angle
of 17 [45]. By contrast, the MEMS scanner actuated
by electrostatic force had a size of 750  750 mm2, a
resonance frequency of 1.76 kHz, and a rotation an-
gle of 8 [46]. A 2D MEMS scanner with dimen-
sions 0.5 mm  0.5 mm and a resonance frequency
of 480 Hz has also been developed [48]. If combined
with a miniature axial scanner in the future, this mir-
ror could be used for 3D imaging of tissue. Recently,
Jung and Tang et al demonstrated a 2 mm diameter
MEMS scanner that achieves superior resolution,
optical angle of 14, and a resonance frequency of
780 Hz [49, 50].
4.3 Thin film piezoelectric (vertical) actuators
Imaging with depth into the tissue requires actuators
that translate the focal volume in the vertical direc-
tion. Various forms of shape memory alloys are cur-
rently used, but are limited in performance by hys-
teresis and slow speeds [42]. Thin-film piezoelectric
materials are promising for future use in endomicro-
scopy to perform vertical translation. These actua-
tors can achieve large displacements with high band-
width using low-voltage and power levels, features
that are compatible with in vivo imaging in medical
endoscopes. The actuation material is a chemical-
solution deposited lead–zirconate–titanate (PZT)
thin film. As shown in Figure 5c, a set of 4 compound
bend-up/bend-down unimorphs can be used to pro-
duce translational motion of a moving stage that
seats a horizontal scanning device. Prototype designs
have shown as much as 120 mm of static displacement
using 4 legs with a length of 920 mm. The system
resonance is observed at a frequency of 200 Hz.
Greater vertical displacement can be achieved by
stacking these legs in the vertical direction [51].
5. Molecular imaging
The commercialized and preclinical instruments de-
scribed above have mostly been demonstrated using
non-specific fluorescence contrast agents. The clini-
cal utility of these instruments can be greatly supple-
mented by integrating them with molecular probes
that are highly specific for disease targets. Molecular
imaging allows for in vivo visualization and char-
acterization of biological processes that occur on a
cellular or sub-cellular scale based on protein ex-
pression [52]. These imaging agents are usually inte-
grated with advanced endoscopic instruments that
are sensitive to fluorescence. Applications include 1)
early cancer detection by imaging molecular changes
that occur before gross morphological abnormalities;
2) personalized medicine by visualizing molecular
targets specific to individual patients; and 3) image
guided therapy by localizing tumor margins and mon-
itoring for recurrence [53].
5.1 Classifications of molecular probes
The best molecular probes are highly specific for
their biological targets, active only in the presence of
disease, and much more intense than the surround-
ing background. For clinical use, the ideal probe
should have rapid binding kinetics (time scale of min-
utes), be easy to label with fluorescent agents in
multiple colors, and have capability for low cost,
large scale synthesis [54]. The two most common
classes of probes being developed for clinical use in-
clude antibodies and peptides. Antibodies are highly
specific for known targets, but have been difficult to
translate into the clinic because of delivery chal-
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lenges, longed serum half-lives, and immunogenicity.
Peptides are short chains of amino acids that have
been successfully selected using phage display tech-
nologies that consist of high diversity, unbiased li-
braries. However, the selection process for specific
peptides can be challenging. While their binding affi-
nity is not as high as that of antibodies, peptides are
much smaller in size, easy to label with fluorescent
dyes, have rapid binding kinetics, and minimal im-
munogenicity.
Molecular probe platforms include activatable,
antibody/affibody, small molecule, peptide, and apta-
mer, as shown in Figure 6. Activatable probes are
designed to generate fluorescence only after coming
into contact with the target. These “smart” probes
are fluorescently quenched in their native state, and
are activated when cleaved by tumor-associated
proteases, such as cathepsin and matrix metallopro-
teinases which play an important role in cell prolif-
eration, invasion, apoptosis, angiogenesis, and me-
tastasis [55]. Antibodies are widely used Y-shaped
gamma globulins (IgG) that bind specifically to anti-
genic targets. They can be labeled with a large selec-
tion of fluorescent dyes, and have been developed
for several molecular targets that have great clinical
relevance, including human epidermal growth factor
receptor (HER2) and epidermal growth factor re-
ceptor (EGFR) [27]. Antibodies may elicit an im-
mune reaction with repeated use, and are costly to
produce in large quantities. Affibodies are small sin-
gle domain proteins that are desirable because of
their small size, leading to rapid tumor localization
and fast clearance [56]. Their utility has been de-
monstrated for in vivo targeting and detection of tu-
mors that over express HER2. Small molecule
probes have been developed for imaging that are ac-
tivated by a change in pH after entering a target cell
and merging with lysosomes [57]. These probes re-
quire a targeting moiety such as HER2 antibody to
attach to the cell. Since non-activated probes do not
emit a signal, the target-to-background ratio is greatly
improved. Aptamers are single-stranded, nuclease-
resistant DNA or RNA molecules [58], and have re-
cently been developed with high affinity and specifi-
city for DLD-1 and HCT 116 colorectal cancer cell
lines in vitro, but this has not yet been demonstrated
in vivo.
5.2 Molecular targets
Targets unique to disease can be over-expressed both
on the cell-surface as well as within the cytoplasm.
For purposes of imaging, the pharmacokinetics of
molecular probes that bind to the cell surface are more
predictable than those that are internalized and bro-
ken down by proteolytic enzymes. Epidermal growth
factor receptor (EGFR), HER2/neu (ERBB2), and
vascular endothelial growth factor (VEGF) receptor
are over-expressed in several cancers, including eso-
phageal, colorectal, breast, and ovarian. Somatosta-
tin receptors (SSTR) are overexpressed in neuro-
endocrine tumors [59]. Over-expressed proteolytic
enzymes activate “smart” probes such as cathepsin-
B and matrix metalloproteinases (MMPs) [60–62].
Apoptosis reporters frequently utilizes effector cas-
pases as targets [63].
5.3 In vivo targeted molecular imaging
Targeted molecular imaging has been demonstrated
mostly in the colon thus far, using different types
of probes on a variety of instrumentation platforms.
A fluorescein-labeled monoclonal antibody against
EGFR has been imaged using confocal laser endo-
microscopy in a xenograft mouse model of colorectal
cancer [27]. Image analysis indicated that fluores-
cence intensity was higher in tumors that have high
EGFR expression than those with low EGFR ex-
pression. Clinical use of peptides was demonstrated
for early detection of colorectal cancer using the
FITC-labeled sequence VRPMPLQ, as shown in Fig-
ure 7 [28]. The peptide bound more specifically to
dysplastic colonocytes than to adjacent normal cells
with 81% sensitivity and 82% specificity on confocal
Figure 6 (online color at:
www.biophotonics-journal.org)
Molecular probe platforms.
Strengths and weaknesses of va-
rious probe platforms being de-
veloped for targeted imaging are
presented.
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laser endomicroscopy. Molecular imaging has also
been demonstrated for early detection of esopha-
geal cancer. Li et al recently identified the peptide
SNFYMPL that preferentially binds to high-grade
dysplasia in Barrett’s esophagus on excised human
specimens, and plans have been made to study this
peptide in a Phase 1 clinical trial [64]. Another FITC-
labeled peptide, ASYNYDA, has been selected to
target dysplastic esophageal mucosa, and has been
demonstrated to have higher fluorescence intensity
for high grade dysplasia in a pilot clinical study using
the AFI endoscope, as shown in Figure 8 [53].
6. Conclusions
Endoscopy is a powerful imaging tool for rapidly
visualizing large surface areas in hollow organs, such
as the colon, esophagus, lung, oropharynx, and sto-
mach. New instruments that are sensitive to fluores-
cence are being developed to observe endogenous
biochemical substrates associated with increased me-
tabolism. In addition, novel optical designs are being
implemented to reduce the instrument size to clearly
visualize the biliary and pancreatic ducts. These hol-
low organs can also be studied with techniques of
endomicroscopy, such as confocal and two-photon,
that perform optical sectioning for looking below the
tissue surface with sub-cellular resolution. These
methods rely on novel scanning and actuation me-
chanisms based on MEMS (microelectromechanical
systems) and PZT (piezoelectric) technologies.
The future of endoscopy lies in the development
of new imaging technologies that allow physicians to
see beyond gross anatomical structures to appreciate
biological function. The molecular properties of tis-
sue possess a significant wealth of information that
reveals details about tissue behavior that can be dis-
covered when properly imaged. Diseases such as
Figure 7 (online color at: www.biophotonics-journal.org) Targeted imaging of colonic dysplasia. In vivo confocal fluores-
cence images of the border between colonic adenoma and normal mucosa showing peptide binding to dysplastic colono-
cytes: (a) endoscopic view, (b) border on confocal endomicroscopy, scale bars: 20 mm. Used with permission.
Figure 8 (online color at: www.biophotonics-journal.org) Targeted imaging of esophageal dysplasia. Targeted detection of
high-grade dysplasia in Barrett’s esophagus with fluorescence imaging. (a) White light endoscopic image of Barrett’s eso-
phagus shows absence of architectural features to guide biopsy for dysplasia. (b) Molecular image after topical administra-
tion of labeled peptides shows increased fluorescence intensity at a site (arrow) of high-grade dysplasia. Used with permis-
sion.
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cancer result from a number and variety of genetic
changes. Thus, the in vivo molecular expression pat-
terns of cells and tissues can provide physicians with
information on how to improve patient management.
Confocal and two-photon endomicroscopy are excit-
ing new techniques that perform optical sectioning
in real time to visualize tissue with sub-cellular de-
tails to provide “in situ histology”. The images are
being created using advancements in miniature scan-
ning mechanisms that operate with high speeds
needed to overcome motion artifact. Progress is also
being made in methods for performing wide-area
imaging that enable observation of large mucosal
surfaces to localize the presence of disease.
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